Login to Your Account

FDA Adcom: 'No Limits' on New Tumor Cell Lines in Vaccines

By Catherine Shaffer
Staff Writer

Thursday, September 20, 2012
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) found no red flags preventing the use of new tumorigenic cell lines for vaccine production, but had plenty of questions and hypotheticals for the experts gathered at Wednesday's meeting.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription